Bessemer Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bessemer Group’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-494,071	Closed	-$1.9M	–	2386
2023 Q2	$1.9M	Hold	494,071	–	–	﹤0.01%	498
2023 Q1	$1.49M	Hold	494,071	–	–	﹤0.01%	510
2022 Q4	$1.01M	Hold	494,071	–	–	﹤0.01%	575
2022 Q3	$1.71M	Hold	494,071	–	–	﹤0.01%	478
2022 Q2	$2.08M	Hold	494,071	–	–	0.01%	430
2022 Q1	$1.5M	Hold	494,071	–	–	﹤0.01%	407
2021 Q4	$2.3M	Hold	494,071	–	–	﹤0.01%	321
2021 Q3	$3.81M	Hold	494,071	–	–	0.01%	260
2021 Q2	$4.25M	Hold	494,071	–	–	0.01%	263
2021 Q1	$5.61M	Buy	+494,071	New	+$7.75M	0.01%	252

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Bessemer Group's DBTX Position: Q3 2023 in Review

Bessemer Group sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 494,071 shares — an estimated $1.9M sold.

Bessemer Group first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $5.61M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Bessemer Group reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bessemer Group sold 494,071 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.9M.
Bessemer Group first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Bessemer Group's Decibel Therapeutics, Inc. Common Stock position peaked at $5.61M in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bessemer Group's 13F filing for Q3 2023, filed 13 Nov 2023.